Dr Steven Shih is currently a myeloma fellow at the Princess Margaret Cancer Centre. He has keen interests in myeloma, immunotherapy and clinical trials. Prior to this, he was a clinical research fellow at the largest haematology research unit in New Zealand where they conducted bispecific antibody trials for both myeloma and lymphoma. Dr Shih qualified as a Clinical and Laboratory Haematologist in 2023 in New Zealand. He has also completed the Global Clinical Scholars Research Training program at the Harvard Medical School.